gliclazide has been researched along with resveratrol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Palsamy, P; Subramanian, S | 1 |
Palsamy, P; Sivakumar, S; Subramanian, S | 1 |
Bilgin, HM; Deniz Obay, B; Elbey, B; Şermet, A; Taşdemir, E; Yazgan, ÜC | 1 |
Aktaş, A; Atamer, Y; Deveci, E; Ezel, T; Kocyigit, Y; Sermet, A; Uysal, E; Yavuz, D | 1 |
5 other study(ies) available for gliclazide and resveratrol
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats.
Topics: Administration, Oral; Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Evaluation, Preclinical; Fructose-Bisphosphatase; Gliclazide; Glucose-6-Phosphatase; Glucosephosphate Dehydrogenase; Glycogen Phosphorylase; Glycogen Synthase; Hexokinase; Hypoglycemic Agents; Kidney; L-Lactate Dehydrogenase; Liver; Male; Niacinamide; Pyruvate Kinase; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2009 |
Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats.
Topics: Animals; Antioxidants; Cytokines; Diabetes Mellitus, Experimental; Gliclazide; Hepatocytes; Hyperglycemia; Hypoglycemic Agents; Inflammation Mediators; Male; Microscopy, Electron, Transmission; Models, Biological; Niacinamide; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2010 |
Comparison of the anti-diabetic effects of resveratrol, gliclazide and losartan in streptozotocin-induced experimental diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Gliclazide; Glycated Hemoglobin; Hypoglycemic Agents; Losartan; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2015 |
Biochemical and Histopathological Investigation of Resveratrol, Gliclazide, and Losartan Protective Effects on Renal Damage in a Diabetic Rat Model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Gliclazide; Hypoglycemic Agents; Immunohistochemistry; Kidney; Losartan; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2015 |